Title:
A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARTISTRY-7)
Phase:
III
Contact:
Werner Diehl / Kontaktperson
Email-Address:
Werner.Diehl@med.uni-heidelberg.de
Clinical Investigator:
Prof. Dr. med. Andreas Schneeweiss
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT05092360
EudraCT-Number:
Keine Registernummer angegeben.